Atara Biotherapeutics (ATRA) Total Non-Current Liabilities (2013 - 2026)
Atara Biotherapeutics (ATRA) posted Total Non-Current Liabilities of $16.48 million for Q2 2026, down 47.1% from $31.15 million a year earlier but up 4.1% from the prior quarter.
Powered by 
Analysis
Atara Biotherapeutics (ATRA) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends
At the end of FY2025, Atara Biotherapeutics' Total Non-Current Liabilities came in at $16.31 million, down 90.3% from FY2024.
- Annual Total Non-Current Liabilities shows a five-year compound annual growth rate of -33.3% (FY2020 to FY2025).
- In prior years, Atara Biotherapeutics' Total Non-Current Liabilities was $167.38 million in FY2024 (+436.5%), $31.2 million in FY2023 (-87.2%), $244.22 million in FY2022 (+30.6%) and $187.01 million in FY2021 (+51.1%).
- Quarterly Total Non-Current Liabilities has run from a low of $15.84 million in Q1 2026 to a high of $259.18 million in Q1 2024 over five years.
- On a year-over-year basis, Total Non-Current Liabilities has declined in each of the last six quarters, with an average decline of 3.5% over the last eight quarters.
- The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q4 2024, with growth of 436.5%; the weakest was Q4 2025, with a decline of 90.3%.
- According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $15.84 million (Q1 2026), $16.31 million (Q4 2025) and $25.16 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 102.65 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Atara Biotherapeutics | 130.64 Mn | 120.74 Mn | 439,000.00 | 14.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.60 Mn |
| Mar 31, 2026 | 14.01 Mn |
| Dec 31, 2025 | 14.52 Mn |
| Sep 30, 2025 | 23.39 Mn |
| Jun 30, 2025 | 29.42 Mn |
| Mar 31, 2025 | 74.11 Mn |
| Dec 31, 2024 | 164.11 Mn |
| Sep 30, 2024 | 229.28 Mn |
| Jun 30, 2024 | 223.99 Mn |
| Mar 31, 2024 | 259.18 Mn |
| Dec 31, 2023 | 26.57 Mn |
| Sep 30, 2023 | 234.78 Mn |
| Jun 30, 2023 | 233.96 Mn |
| Mar 31, 2023 | 231.95 Mn |
| Dec 31, 2022 | 244.22 Mn |
| Sep 30, 2022 | 175.65 Mn |
| Jun 30, 2022 | 173.02 Mn |
| Mar 31, 2022 | 172.35 Mn |
| Dec 31, 2021 | 187.01 Mn |
| Sep 30, 2021 | 137.57 Mn |
API Access
Atara Biotherapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ATRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "ATRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ATRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();